Pharma Archives - Page 3 of 67 - Life Sciences Times

ConcertAI Unveils AI-Powered Precision Suite to Revolutionize Oncology Research and Life Sciences

May 30, 2025

Trinity Life Sciences and Ontada Partner to Enhance Commercial Decision-Making in Community Oncology

May 29, 2025

Pion Inc. Launches DissoSpec, a Fully Integrated System to Revolutionize Drug Dissolution Testing

May 27, 2025

THIS WEEK'S STORIES

GlycoEra Raises $130 Million to Advance Autoimmune Disease Treatment Pipeline

May 27, 2025

enGene Appoints Amy Pott as Chief Global Commercialization Officer Ahead of Anticipated Bladder Cancer Therapy Launch

May 28, 2025

RHEACELL and AOP Health Form Strategic Partnership to Advance Stem Cell Therapies for Rare and Chronic Wound Diseases

May 27, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Pharma

Bambusa Therapeutics Doses First Subject in Phase 1 Trial of Novel Bispecific Antibody BBT002, Gains FDA Clearance for BBT001 IND

ENHERTU Shows Significant Survival Benefit in Advanced Gastric Cancer in Phase 3 Trial

Mythic Therapeutics Reports Promising Early Results for New Lung Cancer Therapy at ASCO 2025

Agenus Unveils Promising ASCO Data on Botensilimab’s Immune Activation in Colorectal Cancer

FDA Approves Alcon’s TRYPTYR for Treatment of Dry Eye Disease

Most Read

Bambusa Therapeutics Doses First Subject in Phase 1 Trial of Novel Bispecific Antibody BBT002, Gains FDA Clearance for BBT001 IND

Outcomes4Me Raises $21 Million to Advance AI-Powered Cancer Care and Expand Globally

ENHERTU Shows Significant Survival Benefit in Advanced Gastric Cancer in Phase 3 Trial

Tempus Launches ‘Fuses’ to Build AI-Driven Diagnostic Platform and Advance Therapeutic Research

EDITOR PICKS

ConcertAI Unveils AI-Powered Precision Suite to Revolutionize Oncology Research and Life Sciences

Trinity Life Sciences and Ontada Partner to Enhance Commercial Decision-Making in Community Oncology

Pion Inc. Launches DissoSpec, a Fully Integrated System to Revolutionize Drug Dissolution Testing

THIS WEEK'S STORIES

GlycoEra Raises $130 Million to Advance Autoimmune Disease Treatment Pipeline

enGene Appoints Amy Pott as Chief Global Commercialization Officer Ahead of Anticipated Bladder Cancer Therapy Launch

RHEACELL and AOP Health Form Strategic Partnership to Advance Stem Cell Therapies for Rare and Chronic Wound Diseases

POPULAR CATEGORY

ABOUT US

FOLLOW US